Biological Pathway Guided Gene Selection Through Collaborative Reinforcement Learning

Ehtesamul Azim, Dongjie Wang, Tae Hyun Hwang, Yanjie Fu, Wei Zhang † · 2025

Read Biological Pathway Guided Gene Selection Through Collaborative Reinforcement Learning by Ehtesamul Azim, Dongjie Wang, Tae Hyun Hwang, Yanjie Fu, Wei Zhang † (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/arxiv-2505-24155.txt.

Introduction

Ehtesamul Azim and co-authors picked disease genes with a learning method in a 2025 paper. Gene data sets hold far more genes than patients, so picking the few genes that matter is a core step in disease work. Plain filters rank genes one by one and can miss how genes act in teams along known body pathways.

Their method lets two learning agents work as a team, guided by pathway maps. One part weighs single gene worth, and the team view keeps picks tied to real body routes. That tie should yield gene sets that stay stable across data sets and make sense to biologists. The aim is picks that both forecast disease and hint at how it works.

Catalog record

CREATOREhtesamul Azim, Dongjie Wang, Tae Hyun Hwang, Yanjie Fu, Wei Zhang †
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE46 KB
VERSION1.0
LICENSEhttp://creativecommons.org/licenses/by/4.0/
RIGHTSCC BY
SOURCEarXiv

Source: https://arxiv.org/abs/2505-24155

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Biological Pathway Guided Gene Selection Through Collaborative Reinforcement Learning Thanks: † \dagger Corresponding Author Ehtesamul Azim, Dongjie Wang, Tae Hyun Hwang, Yanjie Fu, Wei Zhang † Abstract . Gene selection in high-dimensional genomic data is essential for understanding disease mechanisms and improving therapeutic outcomes. Traditional feature selection methods effectively identify predictive genes but often ignore complex biological pathways and regulatory networks, leading to unstable and biologically irrelevant signatures. Prior approaches, such as Lasso-based methods and statistical filtering, either focus solely on individual gene-outcome associations or fail to capture pathway-level interactions, presenting a key challenge: how to integrate biological pathway knowledge while maintaining statistical rigor in gene selection? To address this gap, we propose a novel two-stage framework that integrates statistical selection with biological pathway knowledge using multi-agent reinforcement learning (MARL). First, we introduce a pathway-guided pre-filtering strategy that leverages multiple statistical methods alongside KEGG pathway information for initial dimensionality reduction. Next, for refined selection, we model genes as collaborative agents in a MARL framework, where each agent optimizes both predictive power and biological relevance. Our framework incorporates pathway knowledge through Graph Neural Network-based state representations, a reward mechanism combining prediction performance with gene centrality and pathway coverage, and collaborative learning strategies using shared memory and a centralized critic component. Extensive experiments on multiple gene expression datasets demonstrate that our approach significantly improves both prediction accuracy and biological interpretability compared to traditional methods. † † footnotetext: Release code and preprocessed data can be found at https://github.com/ehtesam3154/bioMARL DOI: XXXXXXX.XXXXXXX Conference: Make sure to enter the correct conference title from your rights confirmation email; June 03–05, 2018; Woodstock, NY ISBN: 978-1-4503-XXXX-X/2018/06 Conference: Proceedings of the 31st ACM SIGKDD Conference on Knowledge Discovery and Data Mining V.2; August 3–7, 2025; Toronto, ON, Canada. Proceedings of the 31st ACM SIGKDD Conference on Knowledge Discovery and Data Mining V.2 (KDD ’25), August 3–7, 2025, Toronto, ON, Canada DOI: 10.1145/3711896.3737198 ISBN: 979-8-4007-1454-2/25/08 CCS: Applied computing Computational genomics CCS: Computing methodologies Feature selection CCS: Computing methodologies Multi-agent reinforcement learning 1. Introduction With the rapid advancement of high-throughput technologies, high-dimension, low-sample-size (HDLSS) data have become increasingly prevalent in biomedical research. Large cohort cancer studies, such as The Cancer Genome Atlas (TCGA) ( Cancer Genome Atlas Research Network, 2013 ) , contain vast amounts of HDLSS genomic data, offering an unprecedented opportunity to understand cancer mechanisms and improve therapeutic outcomes ( Hartmaier et al., 2017 ; Ahmed et al., 2022 ; Baul et al., 2022 ) . However, extracting meaningful insights from this large genomic data requires addressing major analytical challenges, such as statistical randomness, experimental noise, and sample heterogeneity, which often result in inconsistent and biologically or clinically irrelevant gene signatures ( Zhang et al., 2012 ) . A well-known example of this challenge is the discrepancy between two early breast cancer diagnostic gene panels: MammaPrint, a 70-gene signature developed in the Netherlands ( Van’t Veer et al., 2002 ) , and a 76-gene signature from a similar study in San Diego ( Wang et al., 2005 ) . Despite their shared goal of predicting disease progression, only three genes overlapped, highlighting the difficulty of selecting stable gene signatures (i.e., biomarkers). Traditional feature selection methods, such as Lasso-based approaches ( Tibshirani, 1996 ; Lemhadri et al., 2021 ) , have been widely used for biomarker selection due to their ability to enforce sparsity and identify predictive genes. However, these methods primarily focus on individual gene-outcome associations while neglecting the complex biological pathways and regulatory networks that govern gene function. Genes do not operate in isolation; rather, they interact within intricate systems, and integrating biological pathway information as prior knowledge can enhance the robustness and interpretability of selected gene signatures ( Chuang et al., 2007 ) . By leveraging known gene interactions and functional relationships, gene selection methods can improve reproducibility and biological relevance. That said, integrating biological pathway knowledge into gene selection presents unique challenges that extend beyond simple statistical incorporation. While databases like KEGG ( Kanehisa and Goto, 2000 ) provide extensive biological pathway information, effectively leveraging this knowledge requires understanding complex dependencies between genes and their collective impact on biological processes. Most traditional feature selection methods operate independently of biological pathway knowledge, relying purely on statistical patterns in the data ( Zhang et al., 2017 ) . Simple filtering or scoring mechanisms that attempt to integrate pathway information often fail to capture the dynamic nature of gene interactions, leading to suboptimal gene selection. This highlights the need for a framework that models these complex dependencies while making biologically informed decisions about gene importance, ensuring selected gene signatures reflect mechanisms rather than purely statistical associations. Our contribution: A pathway-aware gene selection perspective. We approach the gene selection problem from the perspective of collaborative decision-making, where each gene acts as an intelligent agent that learns when its inclusion benefits both predictive power and biological relevance. The key insight is that: genes function through complex regulatory pathways and networks, interacting via molecular mechanisms, protein-protein interactions, and signaling cascades to drive cellular functions. Our selection agents mirror this biological reality by learning to make decisions that consider both their individual contributions and their collective impact within these pathways. By prioritizing genes with established pathway annotations, our framework leverages decades of experimental validation and enables more interpretable results, as selected genes can be understood within known biological processes. This biological context-aware selection also facilitates cross-study validation and increases the likelihood of identifying druggable targets, as existing therapeutics often target specific pathways. This paper presents a two-stage architecture where pathway-guided statistical pre-filtering creates a biologically relevant reduced gene set, followed by a MARL-based selector where genes function as collaborative agents through sophisticated mechanisms including intelligent reward design, shared memory, and centralized feedback to maintain both statistical significance and biological relevance while optimizing predictive performance. Our key contributions are as follows: \bullet First framework to unify statistical feature selection with pathway knowledge in genomic data analysis. \bullet Novel application of MARL to model gene selection as a collaborative decision process. \bullet Introduction of biologically-informed learning mechanisms that maintain both predictive power and pathway relevance. Figure 1. Framework Overview. BioMARL consists of two key parts: (a) pathway-guided meta-selection combining multiple statistical methods with KEGG pathway information for initial filtering; (b) a pathway-aware multi-agent RL framework for refined selection, with centralized evaluation, shared memory and a multi-component reward system to enhance collaboration among agents while preserving biological relevance. The iteratively generated feature set is evaluated in downstream task, with iterations continuing until optimization or set limit. 2. Problem Statement This paper addresses the challenge of selecting relevant genes from high-dimensional genomic datasets. The goal is to identify a subset of genes that optimize predictive performance while maintaining biological interpretability and pathway-level coherence, addressing the limitations of traditional feature selection methods in capturing complex gene interactions. Formally, given a high-dimensional genomic dataset D with gene set G , where each sample consists of gene expression values and an associated outcome, our objective is to select an optimal subset G_{opt}\subset G such that |G_{opt}|\ll|G| , significantly reducing the dimensionality while preserving predictive power. Through a two-stage selection process, we first obtain a pre-filtered set G_{pre}\subset G using pathway-guided statistical methods, followed by a refined selection process that produces

Read the complete text